Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 23.7B | 45.7B | 42.0B | 43.7B |
Cost of revenue | 22.0B | 20.8B | 15.2B | 23.8B |
Gross profit | 1.7B | 25.0B | 26.8B | 20.0B |
Operating expense | ||||
Research & development | — | 2.6B | 3.3B | 2.4B |
Selling general and admin | 8.8B | 3.7B | 2.9B | 3.1B |
Other operating expenses | — | 303.6M | 2.7B | 816.6M |
Operating income | 1.7B | 12.4B | 11.4B | 7.3B |
Non operating interest income | ||||
Income | — | 512.4M | 822.5M | 791.0M |
Expense | — | 579.7M | 696.3M | 685.7M |
Other income expense | — | — | — | — |
Pretax income | -18.1B | 15.4B | 24.3B | 1.3B |
Tax provision | -379.4M | 3.1B | 5.5B | 383.8M |
Net income | -15.6B | 12.3B | 18.8B | 937.8M |
Basic EPS | -753.4 | 287 | — | -156 |
Diluted EPS | -753.4 | 287 | — | -156 |
Basic average shares | — | 23.1M | — | 23.4M |
Diluted average shares | — | 23.1M | — | 23.4M |
EBITDA | 1.7B | 17.3B | 31.5B | 3.1B |
Net income from continuing op. | — | 12.3B | 18.8B | 937.8M |
Minority interests | -1.4B | -5.7B | -6.4B | -4.6B |
Preferred stock dividends | — | — | — | — |